Proteolysis-targeting chimeras (PROTACs), bifunctional degrader molecules, represent an exciting modality for the development of novel chemical probes and therapeutics that induce protein degradation.1 PROTACs function by simultaneously binding to a target protein and an E3 ligase, forming an intermediate species consisting of a target:PROTAC:ligase ternary complex, leading ultimately to proximity-dependent ubiquitylation and degradation of the target protein via the Ubiquitin Proteasome System (UPS).2-4
Despite the essential role of this ternary intermediate, there is still an incomplete understanding of how the stability and dynamics of the PROTAC ternary complex may impact on degradation efficiency or be used as an optimisation parameter in PROTAC design.
Towards addressing this, we have recently developed an SPR-based assay to measure for the first time the kinetics of target:PROTAC:ligase ternary complex formation and dissociation. We have benchmarked the assay using PROTACs that bind to the bromodomain (BDs) of BET proteins and the E3 ligase VHL. Our data reveals marked differences in rates of ternary complex dissociation (off-rates) for different PROTAC/BD pairs. Further, we observe an apparent correlation between measured differences in ternary complex stability and relative initial intracellular rates of target degradation in response to PROTAC treatment. These studies establish a novel assay to inform future PROTAC development.